Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Novellus Ventures is an early-stage venture capital firm based in Houston, Texas, founded to invest in companies that are transforming the future of healthcare through scientific innovation. Established around 2024-2025, the firm is focused on supporting founders who are developing breakthrough solutions in diagnostics, med-tech, therapeutics, and digital health. The firm operates under the registered entity NOVELLUS VENTURES LS1 GP, LLC, indicating its commitment to life sciences.
Currently, Novellus Ventures has not publicly disclosed any quantitative metrics such as fund size or team size. However, the firm is positioned within the Houston life sciences ecosystem, which is known for its robust healthcare and biotech sectors. The firm emphasizes long-term partnerships and strategic support, aiming to turn scientific insights into real-world clinical impacts.
Novellus Ventures invests in various sectors within life sciences, including advanced diagnostics and imaging, digital medicine, AI-driven therapeutics, med-tech, smart implants, robotics, precision oncology, targeted interventions, and synthetic biology. The firm targets early-stage investments, specifically at the pre-seed, seed, and Series A stages, focusing on companies that are innovating in healthcare.
The firm looks for founders who are converting scientific insights into clinical impact, emphasizing operational insights and network access to assist companies in their growth and development. Novellus Ventures aims to provide strategic support and foster long-term partnerships with its portfolio companies, ensuring they have the resources needed to succeed in a competitive market.
Firoz Jhaver - Managing Partner. Firoz has over 30 years of experience across software, energy, and life sciences, bringing a wealth of knowledge to the firm.
Dr. Hirzallah - Clinical Advisor. Dr. Hirzallah provides expertise in clinical applications and healthcare innovation.
Dr. Dougherty - Medical Director. Dr. Dougherty has a background in medical research and clinical practice, contributing valuable insights to the firm's investment strategy.
Dr. Austin - Biotech Entrepreneur. Dr. Austin's experience in biotech entrepreneurship helps guide the firm’s investment decisions.
Dr. Dharmarajan - Venture Associate. Dr. Dharmarajan supports the firm’s investment activities with a focus on emerging healthcare technologies.
Mr. Hoang - Clinical Translation and Venture Professional. Mr. Hoang brings expertise in clinical translation and venture capital, enhancing the firm's operational support capabilities.
Founders interested in pitching to Novellus Ventures should submit their proposals through the funding application available on their website. The pitch deck should include a clear overview of the business model, market opportunity, and scientific innovation. While specific response time expectations have not been disclosed, founders are encouraged to provide a comprehensive overview to facilitate the review process.
As of now, Novellus Ventures has not publicly disclosed any recent investments, exits, or fund raises. The firm is in the early stages of deployment and has indicated that updates regarding their portfolio and activities will be announced on their website.
What are Novellus Ventures' investment criteria?
Novellus Ventures focuses on early-stage companies in the healthcare sector, particularly those innovating in diagnostics, med-tech, therapeutics, and digital health. They look for founders who can translate scientific insights into real-world clinical applications.
How can founders apply for funding?
Founders interested in applying for funding can visit Novellus Ventures' website, where they provide a funding application. They can also reach out via email at info@novellusventures.com for inquiries.
What makes Novellus Ventures different from other VC firms?
Novellus Ventures emphasizes strategic support, operational insights, and network access, which are crucial for early-stage companies in the healthcare sector. Their focus on scientific innovation sets them apart in the venture capital landscape.
What is the geographic scope of Novellus Ventures?
The firm primarily invests in early-stage healthcare companies located in the United States, particularly those based in or connected to the Houston life sciences ecosystem.
What is the typical check size for investments?
While specific check sizes have not been disclosed, Novellus Ventures focuses on pre-seed, seed, and Series A investments, which typically range from hundreds of thousands to several million dollars, depending on the stage and needs of the startup.
What kind of post-investment involvement can portfolio companies expect?
Novellus Ventures provides operational insights and strategic support to its portfolio companies, fostering long-term partnerships that help startups navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.